Caring Brands Secures Two New US Patents
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 5d ago
0mins
Should l Buy CABR?
Caring Brands announced the issuance of two new United States patents covering proprietary methods and compositions designed to enhance enzymatic activity in hair follicles, further strengthening the Company's intellectual property portfolio supporting its Hair Enzyme Booster product. The newly issued patents, granted by the United States Patent and Trademark Office in January 2026, relate to technologies that increase sulfotransferase enzyme activity to improve the efficacy of topical hair loss treatments.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CABR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CABR
About CABR
Caring Brands, Inc. is a wellness consumer products company. The Company offers several over-the-counter (OTC), and cosmetic, consumer products. Its product pipeline includes a diverse range of products, such as hair-loss treatments, eczema and psoriasis treatments, vitiligo solutions, Jellyfish sting protective suncare line and women’s sexual wellness products that cater to different health and wellness needs. Its hair loss product, Hair Enzyme Booster, is designed to improve Minoxidil efficacy and is available as a topical solution. Its Photocil is used to treat vitiligo and psoriasis. Photocil is a cosmetic product designed to block certain ultraviolet (UV) radiation while allowing other UV radiation to pass through when applied to the skin. NoStingz is used for topical protection from jellyfish, sea lice, and Ultraviolet A radiation/ Ultraviolet B radiation (UVA/UVB) rays. JW-100 is used for the topical treatment of atopic dermatitis (eczema).
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
